Gaozhen Hang

Statistics

Publications

Citations

516

H-Index

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Gaozhen Hang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, molecular oncology, and signal transduction in cancer.

Publications per year

2005–2011

Publications

Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival

Bart Lutterbach, Qinwen Zeng, Lenora J. Davis et al. · Cancer Research · 2007 · 320 citations

Medicine, Molecular Biology, Oncology +17

MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor

Bo‐Sheng Pan, Grace K.Y. Chan, Mélissa Chénard et al. · Cancer Research · 2010 · 82 citations

Medicine, Oncology, Pharmacology +17

Discovery of a 5H-Benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer

Jason D. Katz, James P. Jewell, David Guérin et al. · Journal of Medicinal Chemistry · 2011 · 60 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Aminoglycosides Decrease Glutathione Peroxidase-1 Activity by Interfering with Selenocysteine Incorporation

Diane E. Handy, Gaozhen Hang, John A. Scolaro et al. · Journal of Biological Chemistry · 2005 · 39 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Abstract #3714: In vitro and in vivo antitumor activities of MK-2206, a new allosteric Akt inhibitor

Wei Lu, Debbie Defeo-Jones, Lenora J. Davis et al. · Cancer Research · 2009 · 15 citations

Medicine, Oncology, Pharmacology +13

1–5 of 5